Internalization of near-infrared fluorescently labeled activatable cell-penetrating peptide and of proteins into human fibrosarcoma cell line ht-1080

Journal of Cellular Biochemistry

Volumn 116, Issue 7, 2015, Pages 1222-1231

  Tansi, Felista ^a   Kallweit, Eric ^a,b   Kaether, Christoph ^c   Kappe, Katarina ^d   Schumann, Christina ^b   Hilger, Ingrid ^a   Reissmann, Siegmund ^d,e  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES JENA   (Germany)

^c FRITZ LIPMANN INSTITUTE   (Germany)

^d Jena Bioscience GmbH   (Germany)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

ACTIVATION BY MATRIX METALLO PROTEASES; BOVINE SERUM ALBUMIN; CAD 2; CELL PENETRATING PEPTIDES; CPP DEPENDENT UPTAKE EFFICIENCY; FORMATION OF NON COVALENT COMPLEXES BETWEEN CARGO AND CPP; HISTONES; HIV TAT (47 57); HUMAN FIBROSARCOMA HT 1080 CELLS; INTRACELLULAR TRAFFICKING; MPGalpha; MPGbeta; NEAR INFRARED FLUORESCENT LABELED CARGOS; PROTEODUCIN; SELECTIVITY OF INTERNALIZATION

Indexed keywords

BOVINE SERUM ALBUMIN; CELL PENETRATING PEPTIDE; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCENT DYE; SCAVENGER RECEPTOR; CARBOCYANINE; DY-676; INDOLE DERIVATIVE; MATRIX METALLOPROTEINASE; TRASTUZUMAB;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELL VACUOLE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; CYTOSOL; FIBROSARCOMA CELL LINE; FLUORESCENCE IMAGING; GOLGI COMPLEX; HUMAN; HUMAN CELL; INTERNALIZATION; LIPID COMPOSITION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; CHEMISTRY; DRUG DELIVERY SYSTEM; METABOLISM; PROCEDURES; SYNTHESIS; TUMOR CELL LINE;

BOVINAE;

CARBOCYANINES; CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HUMANS; INDOLES; MATRIX METALLOPROTEINASES; SERUM ALBUMIN, BOVINE; TRASTUZUMAB;

EID: 84929103658     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25075     Document Type: Article

References (43)

1. Abecassis I, Olofsson B, Schmid M, Zalcman G, Karniguian A,. 2003. RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. Experim Cell Res 291: 363-376.
2. Andreev OA, Engelman DM, Reshetnyak YK,. 2010a. PH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents. Mol Membrane Biol 27: 341-352.
3. Andreev OA, Karabadzhak AG, Weerakkody D, Andreev GO, Engelman DM, Reshetnyak YK,. 2010b. PH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exists by a different path. Proc Natl Acad Sci USA 107: 4081-4086.
4. Aguilera TA, Olson ES, Timmers MM, Jiang T, Tsien RY,. 2009. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell-penetrating peptides. Integrative Biol 1: 371-381.
5. Chaloin L, Vidal P, Heitz A, van Mau N, Mery J, Divita G, Heitz F,. 1997. Conformations of primary amphipathic carrier peptides in membrane mimicking environments. Biochemistry 36: 11179-11187.
6. Colditz MJ, Jeffree RL,. 2012. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies. J Clinical Neurosci 19: 1471-1474.
7. Cornelius JF, Slotty PJ, El Khatib M, Giannakis A, Senger B, Steiger HJ,. 2014. Enhancing the effect of 5-aminolevulinic based photodynamic therapy in human meningioma cells. Photodiagnosis and Photodynam Ther 11: 1-6.
8. Crombez L, Aldrian-Herrada G, Konate K, Nguyen QN, McMaster GK, Brasseur R, Heitz F, Divita G,. 2009. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol Therapy 17: 95-103.
9. Dekiwadia CD, Lawrie AC, Fecondo JV,. 2012. Peptide-mediated cell penetration and target delivery of gold nanoparticles into lysosomes. J Pept Sci 18: 527-534.
10. De la Garza-Ramos R, Bydon M, Macki M, Huang J, Tamago RJ, Bydon A,. 2014. Fluorescent techniques in spine surgery. Neurolog Res DOI: http://dx.doi.org/10.1179/1743132814Y
11. Deshayes S, Plenat T, Aldrian-Herrada G, Divita G, Le Grimellec C, Heitz F,. 2004. Primary amphipathic cell penetrating peptides: Structural requirements and interactions with model membranes. Biochemistry 43: 7698-7706.
12. Diao Y, Han W, Zhao H, Zhu S, Liu X, Feng X, Gu J, Yao C, Liu S, Sun C, Pan F,. 2011. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain. J Pept Sci 18: 476-486.
13. Ezzat K, Helmfors H, Tudoran O, Juks C, Lindberg S, Padari K, El-Andaloussi S, Pooga M, Langel Ü,. 2012. Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides. FASEB J 26: 1172-1180.
14. Hamann FM, Brehm R, Pauli J, Grabolle M, Wilhelm F, Kaiser WA, Fischer D, Resch-Genger U, Hilger I,. 2011. Controlled modulation of serum protein binding and biodistribution of asymmetric cyanine dyes by variation of the number of sulfonate groups. Molecular Imaging 10: 258-269.
15. Ignatovich IA, Dizhe EB, Pavlotskaya AV, Akifiev BN, Orlov BSV, Perevozchikov AP,. 2003. Of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. Complex of plasmid DNA with basic domain 278: 47-57.
16. Kalafut D, Anderson TN, Chmielewski J,. 2012. Mitochondrial targeting of cationic amphiphilic polyproline helix. Bioorg & Med Chem Lett 22: 561-563.
17. Keller AA, Mussbach F, Breitling R, Hemmerich P, Kappe K, Wittig B, Braun M, Schaefer B, Lorkowski S, Reissmann S,. 2014. Transduction of proteins into Leishmania tarentolae by formation of non-covalent complexes with cell-penetrating peptides. J Cell Biochem 115: 243-252.
18. Keller AA, Mussbach F, Breitling R, Hemmerich P, Schaefer B, Lorkowski S, Reissmann S,. 2013. Relationships between cargo, cell penetrating peptides and cell type for uptake of non-covalent complexes into live cells. Pharmaceuticals 6: 184-203.
19. Krämer A, Mentrup T, Kleizen B, Rivera-Milla E, Reichenbach D, Enzensperger C, Nohl R, Täuscher E, Görls H, Ploubidou A, Englert C, Werz O, Arndt H-D, Kaether C,. 2013. Small molecules intercept notch signaling and the early secretory pathway. Nature Chem Biol 9: 731-740.
20. Kurzawa L, Pellerano M, Morris MC,. 2010. PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells. Biochim Biophys Acta 1798: 2274-2285.
21. Letoha T, Keller-Pinter A, Kusz E, Koloszi C, Bozso Z, Toth G, Vizier C, Olah Z, Szilak L,. 2010. Cell-penetrating peptide exploited syndecans. Biochim Biophys Acta (Biomembranes) 1798: 2258-2263.
22. Murphy G, Nagase H,. 2008. Review: Progress in matrix metalloproteinase research. Molecular Aspects of Medicine 29: 290-308.
23. Musial-Siwek M, Karabadzhak AG, Andreev OA, Reshetnyak YK, Engelman DM,. 2010. Tuning the insertion properties of pHLIP. Biochim Biophys Acta 1798: 1041-1046.
24. Mussbach F, Martin F, Zoch A, Schaefer B, Reissmann S,. 2011. Tranduction of peptides and proteins into live cells by cell penetrating peptides. J Cell Biochem 112: 3824-3833.
25. Nguyen QT, Olson ES, Aguilera TA, Jiang T, Scadeng M, Ellies LG, Tsien RY,. 2010. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci USA 107: 4317-4322.
26. Olson ES, Aguilera TA, Jiang T, Ellies LG, Nguyen QT, Wong EH, Gross LA, Tsien RY,. 2009. In vivo characterization of activatable cell-penetrating peptides for targeting protease activity in cancer. Integrative Biology 1: 382-393.
27. Olson ES, Tao J, Aguilera TA, Nguyen QT, Ellies LG, Scadeng M, Tsien RY,. 2010. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci USA 107: 4311-4316.
28. Olson ES, Whitney MA, Friedman B, Aguilera TA, Crisp JL, Baik FM, Jiang T, Baird SM, Tsimikas S, Tsien RY, Nguyen QT,. 2012. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. Integrative Biology 4: 595-605.
29. Puppa AD, Rustemi O, Gioffre G, Troncon I, Lombardi G, Rolma G, Sergi M, Munari M, Cecchin D, Gardiman MP, Scienza R,. 2014. Predictive value of intraoperative 5-aminolevulinic acid-induced fluorescence for detecting bone invasion in meningioma surgery. J Neurosurg 120: 840-845.
30. Radis-Baptista G, de la Torre BG, Andreu D,. 2008. A novel cell-penetrating peptide sequence derived by structural minimization of a snake toxin exhibits preferential nucleolar localization. J Med Chem 51: 7041-7044.
31. Reshetnyak YK, Andreev OA, Segala M, Markin VS, Engelman DM,. 2008. Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane. Proc Natl Acad Sci USA 105: 15340-15345.
32. Roomi MW, Monterrey JC, Kalinovsky T, Rath M, Niedzwiecki A,. 2009. Patterns of MMP-2 and MMP-9 expression in human cancer cell lines. Oncology Rep 21: 1323-1333.
33. Savanier EN, Felsen CN, Nashi N, Jiang T, Ellies LG, Steinbach P, Tsien RY, Nguen QuT,. 2013. Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides. Cancer Research 73: 855-864.
34. Sbardella D, Fasciglione GF, Gioia M, Ciaccio M, Tundo GR, Marini S, Coletta M,. 2012. Review: Human matrix metalloproteinases: An ubiquitarian class of enzymes involved in several pathological processes. Molecular Aspects of Medicine 33: 119-208.
35. Shu X, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, Steinbach PA, Tsien RY,. 2009. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science 324: 804-807.
36. Snyder EL, Saenz CC, Denicourt C, Meade BR, Cui X-S, Kaplan IM, Dowdy SF,. 2005. Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides. Cancer Res 65: 10646-10650.
37. Szeto HH, Schiller PW, Zhao K, Luo G,. 2005. Fluorescent dyes alter intracellular targeting and function of cell-penetrating peptides. FASEB J 19: 118-120.
38. Taraboletti G, D'Ascenzo, Borsotti P, Giavazzi R, Pavan A, Dolo V,. 2002. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated compomemts by endothelial cells. Amer J Pathol 160: 673-680.
39. Torchilin VP,. 2008. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Advanced Drug Deliv Rev 60: 548-558.
40. van Duijnhoven SMJ, Robillard MS, Nicolay K, Gruell H,. 2011. Tumor-targeting of MMP-2/9 activatable cell-penetrating probes is caused by tumor-independend activation. J Nuclear Med 52: 279-286.
41. Vives E, Brodin P, Lebleu B,. 1997. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272: 16010-16017.
42. Whitney M, Savariar EN, Friedman B, Levin RA, Crisp JL, Glasgow HL, Lefkowitz R, Adams SR, Steinbach P, Nashi N,. 2013. Ratiometric activatable cell-penetrating peptides provide rapid in vivo readout of thrombin activation. Angewandte Chemie 52: 325-330.
43. Yousif LF, Stewart KM, Horton KL, Kelley SO,. 2009. Mitochondria-penetrating peptides: Sequence effects and model cargo transport. ChemBioChem 10: 2081-2088.